Emergent BioSolutions entering ‘turnaround’ phase, new CEO says
Emergent BioSolutions raised its revenue guidance and dropped a going concern warning. Its CEO is billing this next chapter ...
Emergent BioSolutions announces brincidofovir trial in Africa
Emergent BioSolutions (EBS) announced that brincidofovir will be included in a clinical trial conducted and sponsored by Panther, under the ...
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
PANTHER to conduct clinical trial under the leadership of Africa Centres for Disease Control and PreventionGAITHERSBURG, Md., Nov. 06, 2024 ...
Seeking Alpha on MSN5d
Emergent Biosolutions stock jumps 14% post-market on guidance raise
Emergent Biosolutions (EBS) stock rose 14% post-market after the company raised the lower end of its revenue guidance range ...
Yahoo Finance5d
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa
Nov. 06, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that brincidofovir (brand name TEMBEXA®) will be included in a clinical trial conducted and sponsored by ...
Yahoo Finance5d
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024
Concurrently, Emergent BioSolutions announced that brincidofovir (brand name Tembexa for smallpox treatment) will be included ...
Seeking Alpha5d
Emergent Biosolutions stock jumps 14% post-market on guidance raise
Emergent Biosolutions (NYSE:EBS) stock rose 14% post-market Wednesday after the company raised the lower end of its revenue guidance range and announced a study for its drug brincidofovir in the ...